Learning To Navigate The Synthetically Accessible Chemical Space Using Reinforcement Learning
Over the last decade, there has been significant progress in the field of machine learning for de novo drug design, particularly in deep generative models. However, current generative approaches exhibit a significant challenge as they do not ensure that the proposed molecular structures can be feasibly synthesized nor do they provide the synthesis routes of the proposed small molecules, thereby seriously limiting their practical applicability. In this work, we propose a novel forward synthesis framework powered by reinforcement learning (RL) for de novo drug design, Policy Gradient for Forward Synthesis (PGFS), that addresses this challenge by embedding the concept of synthetic accessibility directly into the de novo drug design system. In this setup, the agent learns to navigate through the immense synthetically accessible chemical space by subjecting commercially available small molecule building blocks to valid chemical reactions at every time step of the iterative virtual multi-step synthesis process. The proposed environment for drug discovery provides a highly challenging test-bed for RL algorithms owing to the large state space and high-dimensional continuous action space with hierarchical actions. PGFS achieves state-of-the-art performance in generating structures with high QED and penalized clogP. Moreover, we validate PGFS in an in-silico proof-of-concept associated with three HIV targets. Finally, we describe how the end-to-end training conceptualized in this study represents an important paradigm in radically expanding the synthesizable chemical space and automating the drug discovery process.
Code (1)
Tasks
Drug DesignDrug DiscoveryNavigatereinforcement-learningReinforcement LearningReinforcement Learning (RL)Similar Papers 제목 키워드 기반
Learning to Navigate in Synthetically Accessible Chemical Space Using Reinforcement Learning
Over the last decade, there has been significant progress in the field of machine learning-based de novo drug discovery, particularly in generative modeling of chemical structures. However, current generative approaches …
Drug DiscoveryNavigatereinforcement-learningReinforcement Learning (RL)+1Molecular Design in Synthetically Accessible Chemical Space via Deep Reinforcement Learning
The fundamental goal of generative drug design is to propose optimized molecules that meet predefined activity, selectivity, and pharmacokinetic criteria. Despite recent progress, we argue that existing generative method…
Deep Reinforcement LearningDrug DesignInductive Biasreinforcement-learning+2ReACT-Drug: Reaction-Template Guided Reinforcement Learning for de novo Drug Design
De novo drug design is a crucial component of modern drug development, yet navigating the vast chemical space to find synthetically accessible, high-affinity candidates remains a significant challenge. Reinforcement Lear…
Representation LearningReinforcement LearningGenerative Artificial Intelligence for Navigating Synthesizable Chemical Space
We introduce SynFormer, a generative modeling framework designed to efficiently explore and navigate synthesizable chemical space. Unlike traditional molecular generation approaches, we generate synthetic pathways for mo…
Drug DiscoveryNavigateProperty PredictionSynCraft: Guiding Large Language Models to Predict Edit Sequences for Molecular Synthesizability Optimization
Generative artificial intelligence has revolutionized the exploration of chemical space, yet a critical bottleneck remains that a substantial fraction of generated molecules is synthetically inaccessible. Current solutio…